<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Granulocyte and monocyte adsorption apheresis (GCAP) has recently shown remarkable effects on <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, which is characterized by <z:mp ids='MP_0001845'>inflammation</z:mp> and neutrophil infiltration </plain></SENT>
<SENT sid="1" pm="."><plain>Pustular <z:hpo ids='HP_0003765'>psoriasis</z:hpo> often shows histological findings of neutrophilic <z:mpath ids='MPATH_691'>pustules</z:mpath> in the epidermis, and in Japan is usually treated with <z:chebi fb="0" ids="4913">etretinate</z:chebi> or <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>However, there are some resistant cases to these therapies </plain></SENT>
<SENT sid="3" pm="."><plain>We performed GCAP on one patient with generalized pustular <z:hpo ids='HP_0003765'>psoriasis</z:hpo> (patient 1) and on one patient with <z:e sem="disease" ids="C0392439" disease_type="Disease or Syndrome" abbrv="">acrodermatitis continua</z:e>, a subtype of pustular <z:hpo ids='HP_0003765'>psoriasis</z:hpo> limited to acral lesions (patient 2) </plain></SENT>
<SENT sid="4" pm="."><plain>Patient 1, a 44-year-old woman suffering from alcoholic liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> and <z:hpo ids='HP_0000939'>osteoporosis</z:hpo> as a result of the liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, received two GCAP sessions because <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> was ineffective </plain></SENT>
<SENT sid="5" pm="."><plain>Patient 2, a 66-year-old man with <z:hpo ids='HP_0000822'>hypertension</z:hpo> who had suffered from a <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> 4 years before, had five GCAP sessions because <z:chebi fb="0" ids="4913">etretinate</z:chebi> was ineffective </plain></SENT>
<SENT sid="6" pm="."><plain>GCAP remarkably improved the <z:mp ids='MP_0001212'>skin lesions</z:mp> in both patients </plain></SENT>
<SENT sid="7" pm="."><plain>No adverse effects were observed either during or after treatment </plain></SENT>
<SENT sid="8" pm="."><plain>From these findings, GCAP could be an effective therapy for refractory cases of pustular <z:hpo ids='HP_0003765'>psoriasis</z:hpo> </plain></SENT>
</text></document>